Hims and Hers Health Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Hims and Hers Health Inc trades at $33.34 (market cap $7.57B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.53. The key difference: Hims and Hers Health Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| HIMS | USIG | |
|---|---|---|
Market Cap | $7.57B | — |
Sector | Health | Fixed Income |
52-Week High | $66.18 | $52.69 |
52-Week Low | $14.52 | $50.50 |
Enterprise Value | $7.95B | — |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
USIG (iShares Broad USD Investment Grade Corporate Bond ETF) trades at $50.605, down 0.27% with bearish technical signals from moving averages. The ETF shows neutral oscillator readings with RSI at 51.10. Recent corporate actions include dividend payments of $0.20-$0.21 per share. Short interest surged 63.4% in April 2026, indicating growing bearish sentiment among traders.
The ETF faces headwinds from rising short interest and bearish technical positioning. Investment grade corporate bond exposure provides stability but current market sentiment suggests caution. The dividend yield remains modest while technical indicators point to potential near-term pressure on the share price.
Trailing returns across standard periods
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →